Recap: Ligand Pharmaceuticals Q4 Earnings

Ligand Pharmaceuticals LGND reported its Q4 earnings results on Thursday, February 17, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Ligand Pharmaceuticals beat estimated earnings by 31.39%, reporting an EPS of $1.8 versus an estimate of $1.37.

Revenue was up $2.48 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.54, which was followed by a 9.2% increase in the share price the next day.

Here's a look at Ligand Pharmaceuticals's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.